Regulatory scrutiny is set to intensify
Vaccines, therapeutics provide growth opportunities
From government benefits to 401(k)s, our experts covered the big topics
From tax planning to economic forecasts, industry experts provided insights
From dealing with Covid-19 to geopolitical upheaval, 2020 has been an interesting year
The volume and value of exempt financings was steady in 2019, while investor participation rose
The new offerings are sold exclusively through investment advisors
A survey from HSBC finds issuers favour solar power, while investors favour hydrogen
A tweet from a crypto expert prompted the drop
Read our recent equities coverage